EV00.F - Evoke Pharma, Inc.
Evoke Pharma, Inc.
420 Stevens Avenue
Suite 370
Solana Beach, CA 92075
United States
858 345 1494
https://evokepharma.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers—Specialty & Generic
Employés à temps plein: 4
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. David A. Gonyer R.Ph. | Co-Founder, CEO & Director | 806,53k | S.O. | 1964 |
| Mr. Matthew J. D'Onofrio MBA | Co-Founder, Chief Bus. Officer, Pres, COO, Exec. VP, Treasurer & Sec. | 557,11k | S.O. | 1970 |
| Dr. Marilyn R. Carlson | Chief Medical Officer | 518,14k | S.O. | 1948 |
| Mr. Christopher Quesenberry | Chief Commercial Officer - Gimoti (TM) | S.O. | S.O. | S.O. |
Description
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Evoke Pharma, Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..
